Catalyst Capital Advisors LLC Trans Medics Group, Inc. Transaction History
Catalyst Capital Advisors LLC
- $4.41 Billion
- Q3 2024
A detailed history of Catalyst Capital Advisors LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 4,800 shares of TMDX stock, worth $315,407. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,800
Previous 6,525
26.44%
Holding current value
$315,407
Previous $982,000
23.32%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding TMDX
# of Institutions
398Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$236 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$174 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$94.8 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$83.7 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$71.9 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.09B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...